Australian Clinical Labs Ltd (AU:ACL) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Australian Clinical Labs Ltd has announced a daily update on its ongoing on-market buy-back program, with a total of 1,205,864 shares bought back prior to the latest day and an additional 33,391 shares bought back on the previous day. This strategic move is part of the company’s efforts to enhance shareholder value and optimize capital structure.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.